Wealthedge Investment Advisors, LLC Adicet Bio, Inc. Transaction History
Wealthedge Investment Advisors, LLC
- $222 Billion
- Q1 2025
A detailed history of Wealthedge Investment Advisors, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Wealthedge Investment Advisors, LLC holds 227,801 shares of ACET stock, worth $143,514. This represents 0.08% of its overall portfolio holdings.
Number of Shares
227,801
Previous 73,764
208.82%
Holding current value
$143,514
Previous $71 Million
142.37%
% of portfolio
0.08%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ACET
# of Institutions
63Shares Held
57.5MCall Options Held
36.9KPut Options Held
16.5K-
Orbimed Advisors LLC San Diego, CA11.4MShares$7.21 Million0.27% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$5.18 Million0.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$4.75 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.82MShares$2.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.02 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $25.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...